Does Tigecycline Have a Place in Therapy for Rickettsial Infection of the Central Nervous System?
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
This brief report documents the safety and efficacy of high-dose tigecycline as a salvage-therapy in in a case series of five patients with serious central nervous system (CNS) rocky mountain spotted fever (RMSF). These severily ill patients were unable to take any oral drug therapy, parenteral doxycycline was unavailable and absorption of oral doxycycline was a concern in these critically ill patients. As far as we know, we report the successfull use of tigecycline for the treatment of rickettsial meningitis for the first time in Italy. We suggest more studies on tigecycline in severe CNS infections from Rickettsia species and multi-drug resistant bacteria, especially the use of tigecycline at higher than standard doses in these life-threathening infectious diseases.
Abstract
This brief report documents the safety and efficacy of high-dose tigecycline as a salvage-therapy in in a case series of five patients with serious central nervous system (CNS) rocky mountain spotted fever (RMSF). These severily ill patients were unable to take any oral drug therapy, parenteral doxycycline was unavailable and absorption of oral doxycycline was a concern in these critically ill patients. As far as we know, we report the successfull use of tigecycline for the treatment of rickettsial meningitis for the first time in Italy. We suggest more studies on tigecycline in severe CNS infections from Rickettsia species and multi-drug resistant bacteria, especially the use of tigecycline at higher than standard doses in these life-threathening infectious diseases.
참고문헌 (20)
- Bradshaw MJ, "Meningoencephalitis due to spotted fever rickettsioses, including rocky mountain spotted fever", Clin Infect Dis, 71, pp.188~195 (2020)
- Yaghoubi S, "Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review", Eur J Clin Microbiol Infect Dis, pp.1~20 (2021)
- "Nationwide shortage of doxycycline: Resources for providers and recommendations for patient care"[URL]
- Barbour A, "Clinical pharmacokinetics and pharmacodynamics of tigecycline", Clin Pharmacokinet, 48, pp.575~584 (2009)
- Rodvold KA, "Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose", J Antimicrob Chemother, 58, pp.1221~1229 (2006)
- Pallotto C, "Cerebrospinal fluid penetration of tigecycline", Scand J Infect Dis, 46, pp.69~72 (2014)
- Ray L, "Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis", Ann Pharmacother, 44, pp.582~586 (2010)
- Kooli I, "Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline", J Glob Antimicrob Resist, 5, pp.62~63 (2016)
- Lauretti L, "First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumannii", J Neurosurg, 127, pp.370~373 (2017)
- Fang YQ, "A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii", Medicine(Baltimore), 96, pp.e7703~ (2017)
- Long W, "Multidrug resistant brain abscess due to Acinetobacter baumannii ventriculitis cleared by intraventricular and intravenous tigecycline therapy : A case report and review of literature", Front Neurol, 9, pp.518~ (2018)
- Tsolaki V, "Intraventricular CNS treatment with colistin-tigecycline combination : A case series", J Crit Care, 47, pp.338~341 (2018)
- Wu Y, "Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy : a case report", J Chemother, 30, pp.49~52 (2018)
- Fang GD, "Comparative efficacy of GAR-936, a novel glycylcycline alone and in combination with vancomycin against highly penicillin-resistant Streptococcus pneumoniae experimental meningitis in rabbits", Abstract 868. Program and abstracts of the 40th Interscience Conference on Antimicrobials and Chemotherapy (ICAAC), September 17–20, 2000, Toronto, Ontario, Canada, pp.51~ (2000), ASM Press
- Blanton LS, "Susceptibility of Rickettsia rickettsii to tigecycline in a cell culture assay and animal model for rocky mountain spotted fever", Am J Trop Med Hyg, 101, pp.1091~1095 (2019)
- Spyridaki I, "Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics", Antimicrob Agents Chemother, 53, pp.2690~2692 (2009)
- Satoh M, "In vitro evaluation of minimum inhibitory concentration of several antibacterial agents against Rickettsia japonica using a plaque reduction assay system", J Infect Chemother, 25, pp.917~919 (2019)
- 이진수, "In Vitro Activity of Tigecycline Against Orientia tsutsugamushi", Yonsei Medical Journal, 57(4), pp.1034~1037 (2016), 연세대학교의과대학[DOI]
- Kuo MJ, "The case a 71-year-old man with fever, acute kidney injury, and a black crustaceous lesion", Kidney Int, 95, pp.239~240 (2019)
- Sachdev SH, "Severe life-threatening Ehrlichia chaffeensis infections transmitted through solid organ transplantation", Transpl Infect Dis, 16, pp.119~124 (2014)